Apollo Hospitals Enter. L

NSE: APOLLOHOSP · Hospital · sector

₹7,844.00NSE close 2026-10-26

Key numbers

Market cap₹1,12,797 cr

Price₹7,844.00

52w high / low₹9,070 / ₹6,696

P/E54.0xSector median 42.5x

P/B11.9xSector median 4.9x

Book value₹659.3

Dividend yield0.26%Sector median 0.17%

ROE23.6%Sector median 12.1%

ROCE21.8%Sector median 13.8%

OPM15.1%Sector median 20.3%

Debt / equity0.60xSector median 0.24x

EV/EBITDA29.1xSector median 23.6x

Interest cover7.1x

Current ratio1.06x

Sales growth 3y+14.9%Sector median +14.1%

Profit growth 3y+33.3%Sector median +14.7%

PEG1.62x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹2,133 cr vs borrowings ₹5,658 cr (FY26): borrowings are higher by ₹3,525 cr.
Borrowings rose in each of the last 3 years (₹2,710 cr → ₹5,658 cr).
Operating profit covered interest 7.1x in the last 12 months.
2.91% of the promoters' shares are pledged (0.8% of all shares).
Operating cash flow was below net profit in 0 of the last 5 years.
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 10% of net profit in the last 12 months.
Dividend paid in 5 of the last 5 financial years.
Price ₹7,844.00 on 2026-10-26: -13.5% from the 52-week high, +17.1% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹8,967.00 · low ₹6,149.60

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5,589	5,527	5,592	5,842	6,304	6,477	6,606	7,044
EBITDA	816	762	770	852	941	946	1,011	1,092
OPM %	14.6%	13.8%	13.8%	14.6%	14.9%	14.6%	15.3%	15.5%
Other income	38	64	61	40	55	53	44	49
Net profit	379	372	390	433	477	502	529	581
EPS (₹)	26.34	25.89	27.10	30.10	33.19	34.94	36.82	40.39
Revenue YoY					+12.8%	+17.2%	+18.1%	+20.6%
Profit YoY					+26.0%	+34.9%	+35.9%	+34.2%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	14,663	16,612	19,059	21,794	25,228	26,430
EBITDA	2,479	2,050	2,393	3,022	3,750	3,990
Net profit	1,056	819	899	1,446	1,942	2,090
EPS (₹)	73.42	56.97	62.50	100.56	135.04	145.34
Revenue growth		+13.3%	+14.7%	+14.3%	+15.8%	+17.2%
Profit growth		-22.4%	+9.7%	+60.9%	+34.3%	+32.8%
Dividend / share (₹)	3.00	17.75	15.00	19.00	20.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+14.9%	+19.0%	+17.2%
Net profit	+33.3%	+66.8%	+32.8%
EPS	+33.3%	+65.9%	–
Share price	–	+4.3% (2y)	-5.1%

Balance sheet

₹ cr	FY22	FY23	FY24	FY25	FY26
Shareholders' equity	–	6,197	6,935	8,212	9,480
Borrowings	–	2,710	3,162	5,275	5,658
Cash & equivalents	–	1,068	1,618	2,792	2,133
Total assets	–	14,428	16,753	20,657	22,197
Fixed assets	–	7,432	8,540	9,816	11,039
Capital work in progress	–	602	845	771	992
Investments	–	96	104	830	906
Receivables	–	2,234	2,515	3,016	3,485
Inventory	–	390	460	481	542
Payables	–	1,916	2,368	2,240	2,252

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	1,616	1,377	1,920	2,136	2,856
Cash from investing	-791	-857	-1,537	-3,381	-2,148
Cash from financing	-768	-633	-311	1,317	-478
Capex	657	1,129	1,137	1,713	1,962
Free cash flow	958	249	784	424	894

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY22	FY23	FY24	FY25	FY26
ROE %	–	13.2%	13.0%	17.6%	20.5%
ROCE %	–	17.1%	17.9%	18.3%	20.3%
Debtor days	–	49	48	51	50
Inventory days	–	17	17	16	15
Payable days	–	82	88	72	63
Cash conversion cycle (days)	–	-16	-23	-5	2
Working capital days	–	22	12	41	6

Shareholding

Holder	% (2026-09-30)
Promoters	28.02%
FIIs	43.18%
DIIs	22.07%
of which Mutual funds	17.19%
of which Insurance	3.78%
Government	0.23%
Public (non-institutions)	6.49%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	29.33%	29.34%	29.34%	28.02%	28.02%	28.02%	28.02%	28.02%

Promoter group	%
M/s. PCR Investments Ltd	18.93%
Ms. Suneeta Reddy	2.04%
Ms. Sangita Reddy	1.69%
Ms. Shobana Kamineni	1.56%
Mr. K Vishweshwar Reddy	1.10%
Ms. Preetha Reddy	0.73%
Ms. Sindoori Reddy	0.22%
Ms. Anuspala Kamineni	0.18%
Dr. Prathap C Reddy	0.17%
Mr. Karthik Anand	0.16%
Mr. Konda Anindith Reddy	0.16%
Mr. Vijay Kumar Reddy	0.16%
Mr. Harshad Reddy	0.15%
Ms. Upasana Konidela	0.15%
Mr. Puansh Kamineni	0.15%

Public holders above 1%	%
SBI Nifty 50 ETF	2.34%
Axis Mutual Fund Trustee Limited	1.77%
ICICI Prudential Balanced Advantage Fund	1.58%
Government Pension Fund Global	1.54%
HDFC Trustee Company Limited	1.48%
Employees Provident Fund Board - Internalmanaged 1	1.35%
Mirae Asset Elss TAX Saver Fund	1.16%
Nippon Life India Trustee Ltd	1.13%
Kotak Arbitrage Fund	1.12%
Aditya Birla SUN Life Mutual Fund	1.07%
Vanguard Total International Stock Index Fund	1.06%
Vanguard Emerging Markets Stock Index Fund, A Series of Vanguard Inter	1.02%

1,72,863 shareholders. Pledged: 2.91% of promoter shares.

Peers in Hospital

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
APOLLOHOSP	₹1,12,797 cr	54.0x	11.9x	23.6%	21.8%	15.1%	+14.9%	0.26%
MAXHEALTH	₹81,266 cr	55.7x	7.6x	14.5%	13.8%	26.1%	+22.4%	0.18%
MANIPALHOS	₹73,581 cr	–	–	–	–	–	–	–
FORTIS	₹55,467 cr	52.9x	5.6x	11.1%	13.2%	22.2%	+13.2%	0.14%
NH	₹33,971 cr	41.4x	7.5x	20.0%	13.7%	18.7%	+20.4%	0.26%
ASTERDM	₹33,523 cr	104.7x	7.3x	8.0%	12.8%	16.7%	-27.0%	0.16%
MEDANTA	₹32,575 cr	58.5x	8.2x	15.1%	15.8%	20.5%	+17.9%	0.04%
KIMS	₹28,123 cr	131.3x	12.5x	9.3%	9.6%	19.5%	+21.1%	0.74%
AGARWALEYE	₹15,065 cr	101.3x	7.4x	7.6%	16.5%	27.8%	–	0.01%
RAINBOW	₹11,802 cr	41.3x	7.2x	18.3%	27.4%	31.5%	+13.2%	0.26%

All 32 companies in Hospital →

Business segments (FY26)

Segment	Revenue	Share	EBIT	Margin
Healthcare services	₹12,750 cr	50.1%	₹2,430 cr	19.1%
Digital health & pharmacy distribution	₹10,808 cr	42.5%	₹399 cr	3.7%
Retail health & diagnostics	₹1,865 cr	7.3%	₹72 cr	3.9%
Others	₹5 cr	0.0%	₹-8 cr	-155.8%

Dividends & corporate actions

Ex-date	Action	Detail
2026-08-14	Dividend	Dividend - Rs 10 Per Sh
2026-02-16	Dividend	Interim Dividend - Rs 10 Per Sh
2025-08-19	Dividend	Dividend - Rs 10 Per Share
2025-02-14	Dividend	Interim Dividend - Rs 9 Per Share
2024-08-16	Dividend	Annual General Meeting/Dividend - Rs 10 Per Share
2024-02-20	Dividend	Interim Dividend - Rs 6 Per Share
2023-08-18	Dividend	Annual General Meeting/Dividend - Rs 9 Per Share
2023-02-24	Dividend	Interim Dividend - Rs 6 Per Share
2022-08-18	Dividend	Annual General Meeting/Dividend - Rs 11.75 Per Share
2021-08-18	Dividend	Annual General Meeting/Dividend - Rs 3 Per Share
2020-09-17	Dividend	Annual General Meeting/Dividend - Rs 2.75 Per Share
2020-02-25	Dividend	Interim Dividend - Rs 3.25 Per Share
2019-09-12	Dividend	Annual General Meeting/Dividend - Rs 6 Per Share
2018-09-12	Dividend	Annual General Meeting/Dividend- Rs 5 Per Share
2017-09-07	Dividend	Annual General Meeting/Dividend - Rs 6/- Per Share
2016-03-22	Dividend	Interim Dividend - Rs 6/- Per Share (Purpose Revised)
2015-07-30	Dividend	Annual General Meeting/Dividend Rs 5.75 Per Share
2014-08-13	Dividend	Annual General Meeting And Dividend Rs.5.75 Per Share
2013-07-25	Dividend	Annual General Meeting And Dividend Rs.5.50 Per Share
2012-07-26	Dividend	Annual General Meeting/Dividend Rs 4 Per Share

Documents

Links go to the original files on the exchange website.

About the company

Healthcare services: Healthcare services offered through hospitals, clinics and online consultations
Digital Health & Pharmacy Distribution: Sales and distribution of pharmaceutical drugs


Sector	Healthcare
Industry	Hospital
Sub-industry	Hospital
Symbol	APOLLOHOSP
BSE code	508869
ISIN	INE437A01024
Face value	₹5.0
Incorporated	1979-12-05
Website	https://www.apollohospitals.com
Plants (India / abroad)	10,606 / 2

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.